Literature DB >> 8036000

Mutations that abolish the ability of Ha-Ras to associate with Raf-1.

M Shirouzu1, H Koide, J Fujita-Yoshigaki, H Oshio, Y Toyama, K Yamasaki, S A Fuhrman, E Villafranca, Y Kaziro, S Yokoyama.   

Abstract

Recent studies have revealed that Ras can associate physically with Raf. In the present study, we tested 34 mutants of Ha-Ras carrying substitution(s) in the region of residues 23-71 for their ability to associate with Raf-1. Mouse Ba/F3 cell lysates were incubated with each mutant Ras protein, in either the guanosine 5'-[gamma-thio]triphosphate (GTP gamma S)- or the guanosine 5'-[beta-thio]diphosphate (GDP beta S)-bound form, and the anti-Ras antibody Y13-238. The immunoprecipitates were analysed for the presence of Raf-1 by Western blotting with an anti-Raf-1 antibody. Six mutants of Ras, E31K, P34G, T35S, D38N, D57A and A59T, failed to bind Raf-1. Mutations N26G, V29A, S39A, Y40W, R41A, V44A, V45E, L56A and T58A partially reduced the ability to bind Raf-1. All the other mutants could associate with Raf-1 with nearly the same efficiency as that of wild-type Ras. Thus, the Raf-I-binding ability of Ras appears to be affected by mutations in the N-terminal region, and in particular, by those in and neighboring the effector region (residues 32-40) and in the region (residues 56-59) flanking the N-terminal of Switch II. The abilities to bind Raf-1 and to induce neurite outgrowth of pheochromocytoma (PC) 12 cells correlate to each other for 22 Ras mutants. However, mutation A59T, which does not reduce the neurite-inducing or transforming activities, abolishes the ability to bind Raf-1. In contrast, mutations Y32F, K42A and L53A, which impair the neurite-inducing activity of Ras, have no effect on the Ras.Raf-1 association. Partially reduced Raf-1-binding ability was observed for mutants V29A, S39A, Y40W, R41A, V44A, L56A and T58A, which exhibit full neurite-inducing activity, and also for mutant V45E, which has no activity of neurite induction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8036000

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  The Ras mutant D119N is both dominant negative and activated.

Authors:  R H Cool; G Schmidt; C U Lenzen; H Prinz; D Vogt; A Wittinghofer
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.

Authors:  R Khosravi-Far; M A White; J K Westwick; P A Solski; M Chrzanowska-Wodnicka; L Van Aelst; M H Wigler; C J Der
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

3.  Positive and negative modulation of H-ras transforming potential by mutations of phenylalanine-28.

Authors:  M H Ricketts; G A Durrheim; H M North; M J van der Merwe; A D Levinson
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

Review 4.  Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.

Authors:  Jonathan M L Ostrem; Kevan M Shokat
Journal:  Nat Rev Drug Discov       Date:  2016-07-29       Impact factor: 84.694

5.  Protein-protein recognition: an experimental and computational study of the R89K mutation in Raf and its effect on Ras binding.

Authors:  J Zeng; M Fridman; H Maruta; H R Treutlein; T Simonson
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

6.  RAS signalling is abnormal in a c-raf1 MEK1 double mutant.

Authors:  D Bottorff; S Stang; S Agellon; J C Stone
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

7.  Tyrosine 106 of CheY plays an important role in chemotaxis signal transduction in Escherichia coli.

Authors:  X Zhu; C D Amsler; K Volz; P Matsumura
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

8.  Two distinct interleukin-3-mediated signal pathways, Ras-NFIL3 (E4BP4) and Bcl-xL, regulate the survival of murine pro-B lymphocytes.

Authors:  R Kuribara; T Kinoshita; A Miyajima; T Shinjyo; T Yoshihara; T Inukai; K Ozawa; A T Look; T Inaba
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 9.  Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling.

Authors:  D T Denhardt
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

10.  Rit mutants confirm role of MEK/ERK signaling in neuronal differentiation and reveal novel Par6 interaction.

Authors:  Jennifer L Rudolph; Geng-Xian Shi; Eda Erdogan; Alan P Fields; Douglas A Andres
Journal:  Biochim Biophys Acta       Date:  2007-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.